Bellerophon Therapeutics
| Region | Nordamerika |
| ISIN | US0787713009 |
| Sektor | Medizintechnik, Biotech |
| Website | https://bellerophon.com/ |
Bellerophon is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases.
| Titel | Autor | Datum |
|---|---|---|
|
NO to COVID!
|
rotten.tom | vor über 2 Jahren |
| Titel | Datum |
|---|---|
| Bellerophon Therapeutics GAAP EPS of -$2.08 misses by $0.06 | vor einem Tag |
|
Bellerophon Therapeutics, Inc.: Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results
Completed Enrollment in INOpulse® REBUILD Phase 3 trial; Pivotal Top-line Data Expected in Mid-20... |
vor einem Tag |
| Bellerophon Therapeutics, Inc. - 8-K, Current Report | vor einem Tag |
| Bellerophon Therapeutics, Inc. - 10-K, Annual Report | vor einem Tag |
| Bellerophon Therapeutics Surges 30% On Share Subscription Agreement With An Institutional Investor | vor 27 Tagen |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Bee Vectoring Technologies (1 Artikel) | |
| Bayer (1 Artikel) | |
| Benz Mining (1 Artikel) | |
| Berkeley Energia (1 Artikel) | |
| Alle anzeigen | |